13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-14, with 27 holding rows worth $115,981,000.
- Accession
- 0001546927-14-000159
- Filer
- CIK 1595855
- Filed
- 2014-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2014
A holdings report, 27 entries on the cover page, a total value of $115,981,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $115,981,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CHIMERIX INC COM | 16934W106 | Stock | 790,000 | $17,333,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 1,216,400 | $14,281,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,660,000 | $10,574,000 | thousands by filing date | |
| PHARMACYCLICS INC | 716933106 | COM | 100,000 | $8,971,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 500,000 | $6,765,000 | thousands by filing date | |
| BIND THERAPEUTICS INC | 05548N107 | Cmn | 492,000 | $6,485,000 | thousands by filing date | |
| INSPIREMD INC | 45779A309 | COM | 2,180,000 | $6,431,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 504,800 | $5,417,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 130,000 | $5,369,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 115,000 | $5,269,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 135,000 | $4,207,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 1,378,584 | $3,488,000 | thousands by filing date | |
| INSYS THERAPEUTICS INC | 45824V209 | COMMON STOCK | 85,800 | $2,680,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 169,700 | $2,289,000 | thousands by filing date | |
| MAZOR ROBOTICS LTD | 57886P103 | SPONSORED ADS | 120,000 | $2,108,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 45,000 | $2,020,000 | thousands by filing date | |
| EVOKE PHARMA INC | 30049G104 | COM | 242,500 | $1,962,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 220,000 | $1,762,000 | thousands by filing date | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 660,000 | $1,716,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 30,000 | $1,397,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 650,000 | $1,352,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 820,000 | $1,197,000 | thousands by filing date | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 338,402 | $1,073,000 | thousands by filing date | |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 320,000 | $730,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 7,200 | $455,000 | thousands by filing date | |
| KIPS BAY MEDICAL INC | 49726K105 | COM | 772,031 | $355,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 13,104 | $295,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-14-000159 | this filing | 2014-08-14 | acceptance time not in the bulk data set |